Blog

For patients with rare diseases, finding the right diagnosis can be a significant challenge. When the disease has no visible symptoms, the challenge becomes even greater.

President-elect Joe Biden held a press conference to announce a team of health experts, including Dr. Rochelle Walensky, who was appointed to be the new Director for the Center for Disease Control and Prevention.

After news broke that Mass General’s Rochelle Walensky, MD, MPH, was tapped for CDC director, friends and colleagues voiced their support on Twitter.

Based on what scientists have learned from other coronaviruses such as the common cold, reports of reinfection of SARS-CoV-2 are not surprising.

During the spring COVID-19 surge, a remarkable team research effort took place to quickly learn more about the disease.

While a vaccine will represent a significant turning point in the fight against COVID-19, there will still be a long way to go.

Mass General is part of a multicenter research effort to overcome key challenges in the long term preservation and reuse of organs, cells, tissues and more.

CAR T cell therapy is a promising form of treatment for cancer, and now Ragon Institute investigator Todd Allen, PhD, recently published findings suggesting dual CAR T cell therapy could be an option for HIV.

Recent research from Ragon Institute researcher Xu Yu, MD, finds that HIV elite controllers can prevent the virus from replicating by sequestering the viral genome in gene deserts.

In a guest blog post, Mass General and Ragon Institute researcher Shiv Pillai, MD, PhD, explains his research examining why COVID-19 immunity may be challenging: The virus could be causing immune system amnesia.